MEI Pharma, Inc. Board of Directors

MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.

Ms. Nicole Chyoko Iida

Ms. Nicole Chyoko Iida

Vice President of Legal Affairs

Mr. David A. Walsey J.D., L.L.M.

Mr. David A. Walsey J.D., L.L.M.

Senior Vice President of Corporate Affairs

Ms. Anne Frese

Ms. Anne Frese

Chief People Officer

Ms. Yomara Gomez-Naiden

Ms. Yomara Gomez-Naiden

Senior Vice President of Operations & Quality

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.